Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Phase IIb Study of IFN-K in Systemic Lupus Erythematosus [Phase 2]
A Phase IIb trial of IFN-K for systemic lupus erythematosus was terminated; results were posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus. [Phase 2]
A Phase 2 pilot study evaluating CC-220 (lenalidomide analog) for treating systemic lupus erythematosus has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus [Phase 3]
Phase 3 trial updating efficacy and safety of anifrolumab versus placebo in adults with active systemic lupus erythematosus. Results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE) [Phase 2]
Phase 2 trial of RC18 given subcutaneously in systemic lupus erythematosus has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus Erythematosus [Phase 2]
Phase 2 trial investigating cyclophosphamide with rabbit antithymocyte globulin (rATG) or rituximab in systemic lupus erythematosus has comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-02-27Clinical Trial Update: Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active Disease [Phase 4]
Phase 4 trial update for Acthar in patients with systemic lupus erythematosus (SLE) who have persistently active disease; study completed wi…
-
CLINICAL_TRIALS trial_result · 2020-02-26Clinical Trial Update: Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus [Phase 1, Phase 2]
A Phase 1/2 study of ACT-334441 in systemic lupus erythematosus has completed with results posted, evaluating safety, tolerability, pharmaco…
-
CLINICAL_TRIALS trial_result · 2020-02-24Clinical Trial Update: Nelfinavir in Systemic Lupus Erythematosus [Phase 2]
Phase 2 trial of nelfinavir in systemic lupus erythematosus was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients [Phase 3]
Phase 3 trial update on belimumab regarding treatment holiday and re-start in systemic lupus erythematosus.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus [Phase 2]
Phase 2 proof-of-concept study for BT063 in systemic lupus erythematosus has completed with results posted.
-
FDA approval · 2020-01-17FDA Approved: BENLYSTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for BENLYSTA (belimumab) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2020-01-17FDA Approved: BENLYSTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approves a supplemental application for Benlysta (belimumab) filed by GlaxoSmithKline, resulting in an update to the product’s labeling.
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115 [Phase 3]
A Phase 3 continuation study in systemic lupus erythematosus and an open-label extension completion for HGS1006-related trials; results post…
-
CLINICAL_TRIALS trial_result · 2019-12-18Clinical Trial Update: A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations [Phase 2]
A Phase 2 study evaluating pharmacokinetics, pharmacodynamics, and safety of anifrolumab in adults with active cutaneous/systemic lupus eryt…
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus [Phase 3]
Phase 3 trial evaluating two doses of anifrolumab versus placebo in adults with active systemic lupus erythematosus, focusing on efficacy an…
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: Belimumab Assessment of Safety in SLE [Phase 4]
Phase 4 trial results assessing the safety of belimumab in systemic lupus erythematosus have been posted.
-
FDA approval · 2019-11-27FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for mycophenolate mofetil submitted by Hikma Pharmaceuticals USA Inc. The approval may involve label…
-
FDA approval · 2019-11-22FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for mycophenolate mofetil submitted by Strides Pharma Science Limited, enabling regulatory updat…
-
FDA approval · 2019-11-15FDA Approved: PREDNISONE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approves ANI Pharmaceuticals' original (generic) application for prednisone, enabling a generic prednisone product to be marketed.
-
CLINICAL_TRIALS trial_result · 2019-10-28Clinical Trial Update: Systemic Lupus Erythematous and Heart Conduction Disorders
Clinical trial update related to systemic lupus erythematosus and heart conduction disorders with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: Transcutaneous Vagus Nerve Stimulation for the Treatment of Lupus [Phase 2]
Phase 2 trial evaluating transcutaneous vagus nerve stimulation for systemic lupus erythematosus was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: The Effect of Metformin on Reducing Lupus Flares [Phase 4]
Phase 4 trial update evaluating whether metformin reduces disease flares in systemic lupus erythematosus.
-
FDA approval · 2019-09-13FDA Approved: BENLYSTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for BENLYSTA (belimumab) from GlaxoSmithKline LLC.
-
CLINICAL_TRIALS withdrawal · 2019-09-13Clinical Trial Update: Acthar SLE (Systemic Lupus Erythematosus) [Phase 4]
Phase 4 clinical trial for Repository Corticotropin Injection in systemic lupus erythematosus was withdrawn.
-
FDA approval · 2019-09-11FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare Inc.'s mycophenolate mofetil. This action updates the regulatory status for th…